• Science and Research

  AR-501, Possible CF Treatment for Chronic Lung Infections, Named Orphan Drug in EU

  Posted by cystic-fibrosis-news-moderator on July 31, 2019 at 6:20 pm

  The European Medicines Agency designation will help to advance AR-501, a non-antibiotic small molecule that works by starving bacteria of iron, as CF treatment. Read more about it here.

  What are your thoughts about this?

  cystic-fibrosis-news-moderator replied 4 years, 9 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply